Skip to main content

Table 1 Patient characteristics and their variables as predictors for disease-specific survival in 335 NSCLC patients (univariate analyses; log-rank test)

From: High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome

Characteristics

Patients

Median survival month

5-year survival %

P

n

(91)

Age

     

  ≤65years

156

(47)

98

55

0.42

  > 65 years

179

(53)

NR

60

Sex

     

  Female

82

(24)

190

64

0.22

  Male

253

(76)

98

56

Smoking

     

  Never

15

(5)

19

43

0.26

  Current

215

(64)

NR

60

  Former

105

(31)

84

55

Performance status

     

  PS 0

197

(59)

NR

63

0.016

  PS 1

120

(36)

64

52

 PS 2

18

(5)

25

33

Weight loss

     

  <10%

303

(90)

190

58

0.76

  >10%

32

(10)

98

57

Histology

     

  SCC

191

(57)

NR

66

0.028

  Adenocarcinoma

113

(34)

54

46

  LCC

31

(9)

98

56

Differentiation

     

  Poor

138

(41)

47

47

<0.001

  Moderate

144

(43)

190

65

  Well

53

(16)

NR

68

Surgical procedure

     

  Lobectomy + Wedge*

243

(73)

190

62

0.007

  Pitunionectomy

92

(27)

37

47

Pathological stage

     

  I

157

(47)

NR

61

<0.001

  II

136

(40)

62

51

  IIIa

42

(13)

17

23

Tumor status

     

  1

85

(25)

190

75

<0.001

  2

188

(56)

84

57

  3

62

(19)

25

36

Nodal status

     

  0

232

(69)

NR

67

<0.001

  1

76

(23)

35

43

  2

27

(8)

18

18

Surgical margins

     

  Free

3)7

(92)

190

59

0.37

  Not free

28

(8)

47

48

Vascular infiltration

     

  No

284

(85)

190

62

0.001

  Yes

51

(15)

27

33

  1. *Wedge, n= 10.
  2. Abbreviations: NR not reached, PS performance status, SCC squanos cell carcinoma, LCC large-cell carcinoma.
  3. Statistically significant results in bold font.